List of works - Georg Hansmann

2015 ESC/ERS GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION

scientific article published in June 2016

2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension

scientific article published on 01 February 2016

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

scientific article published on January 2015

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

article

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

scientific article published on 29 August 2015

2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT

scientific article published on 21 June 2019

Activation of the Metabolic Master Regulator PPARγ: A Potential PIOneering Therapy for Pulmonary Arterial Hypertension

scientific article published on 01 February 2020

An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension

scientific article published in May 2008

Arrival and survival of a 3-week-old boy from Pakistan with an arterial oxygen saturation of 17%

scientific article published on 17 March 2009

Cardiac MR and CT imaging in children with suspected or confirmed pulmonary hypertension/pulmonary hypertensive vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric

scientific article published in May 2016

Chronic TGF-β1 Signaling in Pulmonary Arterial Hypertension Induces Sustained Canonical Smad3 Pathways in Vascular Smooth Muscle Cells

scientific article published on 01 July 2019

Circulating Endothelial Cell Quantification by Microfluidics Chip in Pulmonary Arterial Hypertension

scientific article published on May 2017

Design and validation of an endothelial progenitor cell capture chip and its application in patients with pulmonary arterial hypertension

scientific article published on 7 July 2011

Diagnostics in Children and Adolescents with Suspected or Confirmed Pulmonary Hypertension

scientific article published on 26 October 2016

Diagnostics, monitoring and outpatient care in children with suspected pulmonary hypertension/paediatric pulmonary hypertensive vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The Eur

scientific article published in May 2016

Echocardiographic Reference Values for Right Atrial Size in Children with and without Atrial Septal Defects or Pulmonary Hypertension

scientific article

Echocardiography for the Assessment of Pulmonary Hypertension and Congenital Heart Disease in the Young

scientific article published on 31 December 2020

Emphysema Is-at the Most-Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension

scientific article published on 01 December 2019

Engineered Alginate Hydrogels for Effective Microfluidic Capture and Release of Endothelial Progenitor Cells from Whole Blood ⬇️

scientific article published on March 14, 2011

Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.

scientific article published on May 2016

First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension

scientific article published in April 2017

First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension

scientific article published in January 2017

Full conference report: The first Keystone Symposia Conference on pulmonary vascular disease and right ventricular dysfunction – Current concepts and future therapies

scientific article published in January 2013

Future Applications of the Selective Prostacyclin (IP) Receptor Agonist Selexipag in Pediatric Pulmonary Hypertension

scientific article published on 7 August 2017

Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension

scientific article published on March 2016

Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar

article

Hypoxia drives cardiac miRNAs and inflammation in the right and left ventricle

scientific article published on 23 July 2019

Inhibition of hypoxia-induced apoptosis by modulation of retinoblastoma protein-dependent signaling in cardiomyocytes

scientific article published in November 2002

Interdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologists

scientific article

Mature and immature platelets during the first week after birth and incidence of patent ductus arteriosus

scientific article published on 28 April 2020

Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension.

scientific article

Natural History of Patent Ductus Arteriosus in Very Low Birth Weight Infants after Discharge

scientific article published on August 2015

Neonatal resuscitation on air: it is time to turn down the oxygen tanks [corrected].

scientific article published in October 2004

Non-Invasive Imaging for Congenital Heart Disease: Recent Innovations in Transthoracic Echocardiography

scientific article

Normal Reference Values and z Scores of the Pulmonary Artery Acceleration Time in Children and Its Importance for the Assessment of Pulmonary Hypertension

scientific article published in January 2017

PPARgamma activation: a potential treatment for pulmonary hypertension

scientific article published on December 2009

PPARγ Links BMP2 and TGFβ1 Pathways in Vascular Smooth Muscle Cells, Regulating Cell Proliferation and Glucose Metabolism

scientific article published in May 2017

PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation.

scientific article published in April 2018

Patent ductus arteriosus of the preterm infant

scientific article published on 26 April 2010

Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society

scientific article

Pediatric/Congenital Cardiology Physician Scientists - An Endangered Species

scientific article published on 31 July 2020

Pulmonary Hypertension in Infants, Children, and Young Adults

scientific article

Pulmonary hypertension associated with acute or chronic lung diseases in the preterm and term neonate and infant. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.

scientific article published in May 2016

Pulmonary hypertension in children with congenital heart disease (PAH-CHD, PPHVD-CHD). Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endors

scientific article published in May 2016

Pulmonary hypertension in the intensive care unit. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.

scientific article published in May 2016

Recent Advances in the Treatment of Preterm Newborn Infants with Patent Ductus Arteriosus

scientific article

Recommendations from the Association for European Paediatric and Congenital Cardiology for training in pulmonary hypertension

scientific article published on 26 September 2019

Registries for paediatric pulmonary hypertension

scientific article published in September 2013

Systematic underestimation of oxygen delivery in ventilated preterm infants.

scientific article published on 2 December 2009

The Adult Sprague-Dawley Sugen-Hypoxia Rat Is Still "the One:" A Model of Group 1 Pulmonary Hypertension: Reply to Le Cras and Abman

scientific article published on 01 March 2020

The Need for Comprehensive Cardiac Catheterization in Children With Pulmonary Hypertension

scientific article published in March 2016

The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up

scientific article

The first Keystone Symposia Conference on pulmonary vascular isease and right ventricular dysfunction: Current concepts and future therapies

scientific article published on April 2013

Therapeutic hypothermia in neonates. Review of current clinical data, ILCOR recommendations and suggestions for implementation in neonatal intensive care units

scientific article

Thrombocytopenia in the first 24 hours after birth and incidence of patent ductus arteriosus

scientific article

Trans-right ventricle and transpulmonary metabolite gradients in human pulmonary arterial hypertension

scientific article published on 20 February 2020

Transforming Growth Factor β1- and Bone Morphogenetic Protein 2/PPARγ-regulated MicroRNAs in Pulmonary Arterial Hypertension

scientific article published on 27 June 2017

Transthoracic echocardiography for the evaluation of children and adolescents with suspected or confirmed pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric

scientific article published in May 2016

Transthoracic echocardiography in the evaluation of pediatric pulmonary hypertension and ventricular dysfunction

scientific article

Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.

scientific article published in May 2016

List of works by Georg Hansmann

2015 ESC/ERS GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION

2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT

Activation of the Metabolic Master Regulator PPARγ: A Potential PIOneering Therapy for Pulmonary Arterial Hypertension

An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension

Arrival and survival of a 3-week-old boy from Pakistan with an arterial oxygen saturation of 17%

Cardiac MR and CT imaging in children with suspected or confirmed pulmonary hypertension/pulmonary hypertensive vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric

Chronic TGF-β1 Signaling in Pulmonary Arterial Hypertension Induces Sustained Canonical Smad3 Pathways in Vascular Smooth Muscle Cells

Circulating Endothelial Cell Quantification by Microfluidics Chip in Pulmonary Arterial Hypertension

Design and validation of an endothelial progenitor cell capture chip and its application in patients with pulmonary arterial hypertension

Diagnostics in Children and Adolescents with Suspected or Confirmed Pulmonary Hypertension

Diagnostics, monitoring and outpatient care in children with suspected pulmonary hypertension/paediatric pulmonary hypertensive vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The Eur

Echocardiographic Reference Values for Right Atrial Size in Children with and without Atrial Septal Defects or Pulmonary Hypertension

Echocardiography for the Assessment of Pulmonary Hypertension and Congenital Heart Disease in the Young

Emphysema Is-at the Most-Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension

Engineered Alginate Hydrogels for Effective Microfluidic Capture and Release of Endothelial Progenitor Cells from Whole Blood ⬇️

Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.

First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension

First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension

Full conference report: The first Keystone Symposia Conference on pulmonary vascular disease and right ventricular dysfunction – Current concepts and future therapies

Future Applications of the Selective Prostacyclin (IP) Receptor Agonist Selexipag in Pediatric Pulmonary Hypertension

Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension

Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar

Hypoxia drives cardiac miRNAs and inflammation in the right and left ventricle

Inhibition of hypoxia-induced apoptosis by modulation of retinoblastoma protein-dependent signaling in cardiomyocytes

Interdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologists

Mature and immature platelets during the first week after birth and incidence of patent ductus arteriosus

Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension.

Natural History of Patent Ductus Arteriosus in Very Low Birth Weight Infants after Discharge

Neonatal resuscitation on air: it is time to turn down the oxygen tanks [corrected].

Non-Invasive Imaging for Congenital Heart Disease: Recent Innovations in Transthoracic Echocardiography

Normal Reference Values and z Scores of the Pulmonary Artery Acceleration Time in Children and Its Importance for the Assessment of Pulmonary Hypertension

PPARgamma activation: a potential treatment for pulmonary hypertension

PPARγ Links BMP2 and TGFβ1 Pathways in Vascular Smooth Muscle Cells, Regulating Cell Proliferation and Glucose Metabolism

PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation.

Patent ductus arteriosus of the preterm infant

Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society

Pediatric/Congenital Cardiology Physician Scientists - An Endangered Species

Pulmonary Hypertension in Infants, Children, and Young Adults

Pulmonary hypertension associated with acute or chronic lung diseases in the preterm and term neonate and infant. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.

Pulmonary hypertension in children with congenital heart disease (PAH-CHD, PPHVD-CHD). Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endors

Pulmonary hypertension in the intensive care unit. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.

Recent Advances in the Treatment of Preterm Newborn Infants with Patent Ductus Arteriosus

Recommendations from the Association for European Paediatric and Congenital Cardiology for training in pulmonary hypertension

Registries for paediatric pulmonary hypertension

Systematic underestimation of oxygen delivery in ventilated preterm infants.

The Adult Sprague-Dawley Sugen-Hypoxia Rat Is Still "the One:" A Model of Group 1 Pulmonary Hypertension: Reply to Le Cras and Abman

The Need for Comprehensive Cardiac Catheterization in Children With Pulmonary Hypertension

The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up

The first Keystone Symposia Conference on pulmonary vascular isease and right ventricular dysfunction: Current concepts and future therapies

Therapeutic hypothermia in neonates. Review of current clinical data, ILCOR recommendations and suggestions for implementation in neonatal intensive care units

Thrombocytopenia in the first 24 hours after birth and incidence of patent ductus arteriosus

Trans-right ventricle and transpulmonary metabolite gradients in human pulmonary arterial hypertension

Transforming Growth Factor β1- and Bone Morphogenetic Protein 2/PPARγ-regulated MicroRNAs in Pulmonary Arterial Hypertension

Transthoracic echocardiography for the evaluation of children and adolescents with suspected or confirmed pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric

Transthoracic echocardiography in the evaluation of pediatric pulmonary hypertension and ventricular dysfunction

Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.